Cargando…
Cross Interaction between M2 Muscarinic Receptor and Notch1/EGFR Pathway in Human Glioblastoma Cancer Stem Cells: Effects on Cell Cycle Progression and Survival
Glioblastomas (GBM) are the most aggressive form of primary brain tumors in humans. A key feature of malignant gliomas is their cellular heterogeneity. In particular, the presence of an undifferentiated cell population of defined Glioblastoma Stem cells (GSCs) was reported. Increased expression of a...
Autores principales: | Cristofaro, Ilaria, Alessandrini, Francesco, Spinello, Zaira, Guerriero, Claudia, Fiore, Mario, Caffarelli, Elisa, Laneve, Pietro, Dini, Luciana, Conti, Luciano, Tata, Ada Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140674/ https://www.ncbi.nlm.nih.gov/pubmed/32182759 http://dx.doi.org/10.3390/cells9030657 |
Ejemplares similares
-
Mir-34a-5p Mediates Cross-Talk between M2 Muscarinic Receptors and Notch-1/EGFR Pathways in U87MG Glioblastoma Cells: Implication in Cell Proliferation
por: Di Bari, Maria, et al.
Publicado: (2018) -
M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition
por: Cristofaro, Ilaria, et al.
Publicado: (2020) -
The Combined Treatment with Chemotherapeutic Agents and the Dualsteric Muscarinic Agonist Iper-8-Naphthalimide Affects Drug Resistance in Glioblastoma Stem Cells
por: Guerriero, Claudia, et al.
Publicado: (2021) -
M2 Muscarinic Receptor Activation Impairs Mitotic Progression and Bipolar Mitotic Spindle Formation in Human Glioblastoma Cell Lines
por: Di Bari, Maria, et al.
Publicado: (2021) -
The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells
por: Lucianò, Anna Maria, et al.
Publicado: (2020)